Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinomaKoji Miyahara, Kazuhide Yamamoto, Kazuhiro Nouso et al.|Journal of Gastroenterology and Hepatology|2011Cited by 90
Clinical utility of high-throughput glycome analysis in patients with pancreatic cancerKazuhiro Nouso, Kazuhide Yamamoto, Yuki Morimoto et al.|Journal of Gastroenterology|2013Cited by 54
Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinomaHideaki Kinugasa, Kazuhide Yamamoto, Kazuhiro Nouso et al.|Journal of Gastroenterology|2011Cited by 44
The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosisYasuto Takeuchi, Kazuhide Yamamoto, Fusao Ikeda et al.|Journal of Gastroenterology|2012Cited by 42
Prognostic importance of fucosylated alpha‐fetoprotein in hepatocellular carcinoma patients with low alpha‐fetoproteinKazuhiro Nouso, Kazuhide Yamamoto, Yoshiyuki Kobayashi et al.|Journal of Gastroenterology and Hepatology|2011Cited by 36